!
!
Sign in / Join ICS
Home
A Double-Blind, Placebo-Controlled Trial of Flexible-Dose Fesoterodine for Overactive Bladder
Dmochowski R
1
, Peters K M
2
, Morrow J D
3
, Guan Z
3
, Gong J
3
, Sun F
3
, Siami P F
4
, Staskin D R
5
Abstract Category
Pharmacology: Clinical
Abstract 715
Read by Title
Scientific Non Discussion Abstract Session 34
1.
Vanderbilt University Medical Center, Nashville, TN, USA,
2.
William Beaumont Hospital, Royal Oak, MI, USA,
3.
Pfizer Inc, New York, NY, USA,
4.
Deaconess Clinic, Evansville, IN, USA,
5.
Weill-Cornell Medical College, New York, NY
Links
Abstract PDF
Edit Abstract
Abstract Centre
Abstract
24/04/2024 18:58:30